Bone health advances

By Traci Peterson

A UT Arlington researcher’s recently published study is being heralded as an advance in understanding that could one day influence the treatment of patients with difficult to heal bone fractures and diseases like arthritis.

Rhonda Prisby, an assistant professor of kinesiology in the College of Education and Health Professions, is the lead author on an article published in the November issue of the Journal of Bone and Mineral Research, the official publication of the American Society for Bone and Mineral Research. She collaborated with French and Canadian scientists on a study of parathyroid hormone or PTH.

PTH is often used as a treatment for osteoporosis. It binds to bone cells to stimulate an increase in bone mass. Prisby’s team wanted to examine the interaction between PTH and vascular endothelial growth factor or VEGF A, a protein released in the body to create new blood vessels.

“When we administered PTH intermittently for 15 and 30 days we saw increases in bone mass just as we expected,” Prisby said. “But bone blood vessel numbers were decreased with PTH. That was the opposite of what we expected.”

Instead, researchers noticed that by working through a mechanism related to the VEGF A, PTH caused small blood vessels in the bones to redistribute themselves closer to the surface of the bone. Being closer to the surface of the bone allowed the small blood vessels to more efficiently support growth through delivery of nutrients and oxygen and elimination of waste. That redistribution of the small blood vessels contributed to the increased bone mass, the team concluded.

“To our knowledge, this is the first investigation to demonstrate that bone marrow blood vessels have the capacity to alter their spatial location in response to stimuli and relocalize to the vicinity of bone-forming sites,” the study, which is available online, said.

Having a researcher with Prisby’s talent at UT Arlington benefits students in the classroom and in the lab, said Jeanne Marcum Gerlach, dean of the College of Education and Health Professions.

“Her research is so valuable and she’s one of the top in her field,” Gerlach said. “Her work shows students the real-world applications that research can achieve.”

A commentary in the November issue of the journal singled out both the methods used by Prisby and the research team and their results for praise.

Dwight A. Towler, Ira M. Lang Professor of Medicine, Barnes-Jewish Hospital at Washington University Medical Center, said: “This unparalleled, quantitatively robust analysis of bone vascular anatomy and its regulation by PTH has provided truly novel insights into how anabolic signals control and coordinate bone mass accrual via VEGF signaling in the bone-vascular axis.”

Towler’s commentary said a fundamental understanding of bone-vascular interactions could have a major impact on strategies to build new in everything from cancer cases to old age.

Related Stories

Timing is everything in combination therapy for osteoporosis

date Nov 04, 2010

The adult human skeleton undergoes constant remodeling, with new bone forming at sites that have been broken down by a precise process called resorption. During remodeling, skeletal stem cells are recruited to resorption ...

Procedure developed at Yale creates new bone

date Feb 14, 2008

A new technique that combines bone marrow removal and injection of a hormone helps promote rapid formation of new bone at targeted locations in the body, it was reported by Yale School of Medicine this month in Tissue En ...

Recommended for you

Organ transplant rejection may not be permanent

date 5 hours ago

Rejection of transplanted organs in hosts that were previously tolerant may not be permanent, report scientists from the University of Chicago. Using a mouse model of cardiac transplantation, they found that immune tolerance ...

Researchers find key mechanism that causes neuropathic pain

date 7 hours ago

Scientists at the University of California, Davis, have identified a key mechanism in neuropathic pain. The discovery could eventually benefit millions of patients with chronic pain from trauma, diabetes, shingles, multiple ...

Deep sea light shines on drug delivery potential

date 7 hours ago

A naturally occurring bioluminescent protein found in deep sea shrimp—which helps the crustacean spit a glowing cloud at predators—has been touted as a game-changer in terms of monitoring the way drugs ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.